Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Affordable Care Act
    • Consumer-Driven Health Care
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Drug Prices & Regulations
    • Health Economics & Costs
    • Health Insurance
    • Health Reform
    • Medical Tourism
    • Medicare
    • Single-Payer/Medicare-for-All
    • Telemedicine
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Category: John C. Goodman

Thursday Links

Posted on February 2, 2023February 2, 2023 by John C. Goodman
  • Video: A Canadian describes what socialized medicine is like in Canada. Get ready to hit your pause button to appreciate the examples.
  • If you used GoodRx to find bargains on your medications, it sent your sensitive health data to tech companies like Meta and Google to use for advertising, according to the FTC.
  • Researchers from Johns Hopkins found that 54 percent of people believe landlords should be allowed to deny housing to people with drug addiction and 64 percent believe employers should be allowed to deny them employment.  But if addiction is defined as a “disability,” none of this would be legal.
  • What a Democrat aligned advocacy group wants from Congress on health care: Continue Obamacare subsidies for the rich; extend Medicare drug price controls to everyone else; hearing, dental and eye care benefits for Medicare enrollees – regardless of income and despite the fact that those benefits are available for free from Medicare Advantage plans.
+

Wednesday Links

Posted on February 1, 2023 by John C. Goodman
  • The human circulatory system is 60,000 miles long.
  • While waiting for government price negotiations to begin, Pfizer Inc. and Bristol-Myers Squibb Co. have raised prices on nearly 1,000 products so far this year.
  • Matt Holt discovers that he pays more for drugs than his insurer does – just like Medicare enrollees. Too bad he didn’t do more to help stop the congressional Democrats from rescinding the Trump executive order that would have ended this practice—at least for Medicare.
  • Are politicians playing doctor on marijuana, or are they just getting big brother out of the way?
  • JAMA: AI can’t be included as a coauthor on published articles.
+

Wednesday Links

Posted on January 25, 2023January 25, 2023 by John C. Goodman
  • Blue Cross say its reforms would save $767B over 10 years. Chief among them: pay the same price for medical care, regardless of where it is delivered. That means a facility can’t bill a higher rate to Medicare, just because it has a link to a hospital.
  • To save a child from a rare disease, a one-time injection costs $1.7 million. (NYT) I don’t have a problem with the cost. But who is going to pay for it?
  • Should doctors bill for answering patients’ emails? (NYT) I say, yes. Other professionals bill by time. Why should doctors do the same?
  • Ten myths About nutrition. Myth No 1: fresh is better than frozen, canned or dried fruits and vegetables.  (NYT)
  • 3 problems with Covid boosters: (1) the virus is evolving much faster than the vaccines can be updated; (2) vaccines have hard-wired our immune systems to respond to the original Wuhan strain, so we churn out fewer antibodies that neutralize variants targeted by updated vaccines; (3) antibodies rapidly wane after a few months.  (WSJ)
+

Tuesday Links

Posted on January 24, 2023January 24, 2023 by John C. Goodman
  • Paragon study: In 2023, the federal government is expected to spend 6.2 percent of the economy (or more than $1.6 trillion) on mandatory health programs. The Congressional Budget Office (CBO) estimates that within 30 years, the federal government will annually spend at least 9 percent of the economy on those programs. And this is a conservative estimate.
  • A little-noticed provision of the omnibus spending bill could give the Food and Drug Administration (FDA) the power to ban off-label use of approved therapies, even though 1 in 5 prescriptions written are for an off-label use.
  • Study: Laughter really is contagious – and that’s good. (WaPo)
  • Diversity training not only doesn’t work, it may actually backfire. So why are we spending $3.4B a year on it? (NYT)
  • Fourth Quarter lobbying: almost $7 million by the American Hospital Association and $6.6 million by PhRMA. As Milton Friedman said, the question is not why we get so many bad laws; the question is, why aren’t things worse?
  • Amazon will sell generic drugs for as little as $5 a month. But, no Medicare or Medicaid or private insurance.
  • 25 of the 37 novel drugs approved in 2022, were first approved in the US.
+
  • 1
  • 2
  • 3
  • 4
  • …
  • 61
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 9 other subscribers

Popular Topics

©2023 The Goodman Institute Health Blog | Website by Lexicom